689 related articles for article (PubMed ID: 33173431)
1. Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats.
Alqahtani F; Mohany M; Alasmari AF; Alanazi AZ; Belali OM; Ahmed MM; Al-Rejaie SS
Int J Med Sci; 2020; 17(18):3098-3106. PubMed ID: 33173431
[No Abstract] [Full Text] [Related]
2. LCZ696 Protects against Diabetic Cardiomyopathy-Induced Myocardial Inflammation, ER Stress, and Apoptosis through Inhibiting AGEs/NF-κB and PERK/CHOP Signaling Pathways.
Belali OM; Ahmed MM; Mohany M; Belali TM; Alotaibi MM; Al-Hoshani A; Al-Rejaie SS
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163209
[TBL] [Abstract][Full Text] [Related]
3. LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats.
Mohany M; Alanazi AZ; Alqahtani F; Belali OM; Ahmed MM; Al-Rejaie SS
PeerJ; 2020; 8():e9196. PubMed ID: 32596035
[TBL] [Abstract][Full Text] [Related]
4. LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone.
Kusaka H; Sueta D; Koibuchi N; Hasegawa Y; Nakagawa T; Lin B; Ogawa H; Kim-Mitsuyama S
Am J Hypertens; 2015 Dec; 28(12):1409-17. PubMed ID: 25762811
[TBL] [Abstract][Full Text] [Related]
5. Effect of Neprilysin Inhibition for Ischemic Mitral Regurgitation after Myocardial Injury.
Lee S; Hwang HS; Song N; Kang GH; Choi KH; Ji E; Song JM; Kang DH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445301
[TBL] [Abstract][Full Text] [Related]
6. Renal protective effects and mechanisms of the angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome.
Li Y; Kang L; Rong K; Zhang Y; Suo Y; Yuan M; Bao Q; Shao S; Tse G; Li R; Liu T; Li G
Life Sci; 2021 Sep; 280():119692. PubMed ID: 34102189
[TBL] [Abstract][Full Text] [Related]
7. Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats.
Miyoshi T; Nakamura K; Miura D; Yoshida M; Saito Y; Akagi S; Ohno Y; Kondo M; Ito H
Cardiol J; 2019; 26(5):575-583. PubMed ID: 29718530
[TBL] [Abstract][Full Text] [Related]
8. The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse Model.
Chiu HW; Wu CH; Lin WY; Wong WT; Tsai WC; Hsu HT; Ho CL; Cheng SM; Cheng CC; Yang SP; Li LH; Hua KF
Inflammation; 2024 Apr; 47(2):696-717. PubMed ID: 38319541
[TBL] [Abstract][Full Text] [Related]
9. LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease.
Suematsu Y; Jing W; Nunes A; Kashyap ML; Khazaeli M; Vaziri ND; Moradi H
J Card Fail; 2018 Apr; 24(4):266-275. PubMed ID: 29325796
[TBL] [Abstract][Full Text] [Related]
10. Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats.
Imran M; Hassan MQ; Akhtar MS; Rahman O; Akhtar M; Najmi AK
Clin Exp Hypertens; 2019; 41(1):62-69. PubMed ID: 29595329
[TBL] [Abstract][Full Text] [Related]
11. LCZ696 attenuates sepsis-induced liver dysfunction in rats; the role of oxidative stress, apoptosis, and JNK1/2-P38 signaling pathways.
Mohyeldin RH; Alaaeldin R; Sharata EE; Attya ME; Elhamadany EY; Fathy M
Life Sci; 2023 Dec; 334():122210. PubMed ID: 37883863
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts.
Li X; Braza J; Mende U; Choudhary G; Zhang P
Sci Rep; 2021 Aug; 11(1):16542. PubMed ID: 34400686
[TBL] [Abstract][Full Text] [Related]
13. LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice.
Suematsu Y; Miura S; Goto M; Matsuo Y; Arimura T; Kuwano T; Imaizumi S; Iwata A; Yahiro E; Saku K
Eur J Heart Fail; 2016 Apr; 18(4):386-93. PubMed ID: 26749570
[TBL] [Abstract][Full Text] [Related]
14. Sacubitril/valsartan alleviates sunitinib-induced cardiac fibrosis and oxidative stress via improving TXNIP/TRX system and downregulation of NF-ĸB/Wnt/β-catenin/SOX9 signaling.
Mohamad HE; Askar ME; Shaheen MA; Baraka NM; Mahmoud YK
Int Immunopharmacol; 2024 May; 132():111963. PubMed ID: 38560962
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction.
Zhang Y; Yuan M; Suo Y; Yang Q; Shao S; Li Y; Wang Y; Bao Q; Liu T; Li G
Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):848-857. PubMed ID: 35596518
[TBL] [Abstract][Full Text] [Related]
16. LCZ696 ameliorates lipopolysaccharide-induced endothelial injury.
Gao A; Wang Y; Gao X; Tian W
Aging (Albany NY); 2021 Apr; 13(7):9582-9591. PubMed ID: 33839697
[TBL] [Abstract][Full Text] [Related]
17. Fisetin, a tetra hydroxy flavone recuperates antioxidant status and protects hepatocellular ultrastructure from hyperglycemia mediated oxidative stress in streptozotocin induced experimental diabetes in rats.
Prasath GS; Subramanian SP
Food Chem Toxicol; 2013 Sep; 59():249-55. PubMed ID: 23791753
[TBL] [Abstract][Full Text] [Related]
18. The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease.
Mohany M; Ahmed MM; Al-Rejaie SS
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359384
[TBL] [Abstract][Full Text] [Related]
19. Isopulegol Mitigates Hyperglycemia Mediated Oxidative and Endoplasmic Reticulum Stress in HFD/STZ Induced Diabetic Rats.
Sankaranarayanan C; Kalaivani K
Arch Med Res; 2020 Apr; 51(3):204-214. PubMed ID: 32111490
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy.
von Lueder TG; Wang BH; Kompa AR; Huang L; Webb R; Jordaan P; Atar D; Krum H
Circ Heart Fail; 2015 Jan; 8(1):71-8. PubMed ID: 25362207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
